193. プラダー・ウィリ症候群 Prader-Willi syndrome Clinical trials / Disease details

臨床試験数 : 113 / 薬物数 : 111 - (DrugBank : 26) / 標的遺伝子数 : 48 - 標的パスウェイ数 : 102

17 trials found

diseases per page:

Showing 1 to 10 of 17 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2100046551	2021-05-18	2021-05-21	Multimodal magnetic resonance imaging changes in Prader-Willi syndrome before and after growth hormo ...	Application of multimodal magnetic resonance imaging in pre - and post-treatment evaluation of recom ...	Prader-Willi sydrome	Prader-Willi sydrome group treated with rhGH:Treat with rhGH;Prader-Willi sydrome group treated with ...	Cai Jinhua	NULL	Recruiting	0	16	Both	Prader-Willi sydrome group treated with rhGH:40;Prader-Willi sydrome group treated without rhGH:40;Normal development group:40;	N/A	China
2	JPRN-jRCT2031200351	09/02/2021	08/02/2021	Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS	A PHASE 3 MULTICENTER, OPEN LABEL, MULTI COHORT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SOMATRO ...	Prader-Willi Syndrome	Biological: somatropin- GH naive pediatric cohort somatropin0.245 mg/kg/week Biological: somatropin- ...	Kawai Norisuke	NULL	Not Recruiting	>=	Not applicable	Both	30	Phase 3	Japan
3	NCT04697381 (ClinicalTrials.gov)	February 6, 2021	4/1/2021	Study of the Efficacy and Safety of Somatropin in Japanese Participants With PWS	A PHASE 3 MULTICENTER, OPEN LABEL, MULTI COHORT STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SOMATRO ...	Prader-Willi Syndrome	Biological: somatropin - GH naïve pediatric cohort;Biological: somatropin - GH treated cohort;Biologic ...	Pfizer	NULL	Active, not recruiting	0 Years	N/A	All	32	Phase 3	Japan
4	ChiCTR1900027464	2019-12-01	2019-11-14	Efficacy and safety of anastrozole combined with growth hormonein the treatment of Prader Willi synd ...	Efficacy and safety of anastrozole combined with growth hormonein the treatment of Prader Willi synd ...	Prader-Willi syndrome	control group:Single rhGH therapy;observation group:Anastrazole combined with growth hormone therapy;	Children's Hospital of Zhejiang University School of Medicine	NULL	Pending			Male	control group:20;observation group:20;	Phase 4	China
5	ChiCTR1900022809	2019-05-01	2019-04-26	Efficacy and safety of growth hormone in the treatment of Prader-Willi syndrome	Efficacy and safety of growth hormone in the treatment of Prader-Willi syndrome	Prader-Willi syndrome	control group:Routine treatment such as rehabilitation;Treated group:treatment with growth hormone;	Children's Hospital of Zhejiang University School of Medicine	NULL	Pending			Both	control group:20;Treated group:50;	N/A	China
6	NCT03554031 (ClinicalTrials.gov)	April 14, 2018	30/5/2018	A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth HormoneInjection in Patients ...	A Single Arm, Multicenter Phase III Clinical Trial to Evaluate the Efficacy and Safety of Recombinan ...	Prader-Willi Syndrome	Drug: Recombinant Human Growth Hormone (rhGH) Injection	GeneScience Pharmaceuticals Co., Ltd.	Children's Hospital of Fudan University;Tongji medical college huazhong university of science & tech ...	Unknown status	1 Month	5 Years	All	30	Phase 3	China
7	EUCTR2017-002164-41-ES (EUCTR)	03/07/2017	21/06/2017	Study with adult patients with Prader-Willi syndrome, which evaluate the effect of growth hormonethe ...	Growth hormonetherapy in adults with Prader-Willi syndrome: Effect on muscle tone assessed by functi ...	Patients with Prader-Willi Syndrome (SPW) with Growth hormonedeficit. MedDRA version: 20.0;Level: PT ...	Trade Name: Genotonorm Miniquick 0,2 mg INN or Proposed INN: RECOMBINANT HUMAN GROWTH HORMON Other des ...	Fundació Parc Taulí	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes		Phase 4	Spain
8	NCT03616509 (ClinicalTrials.gov)	June 19, 2017	27/7/2018	GH in Adults With PWS, Effect on Hypotonia Evaluated by Functional MRI, Relationship With Strength a ...	Treatment With Growth Hormonein Adults With PWS, Effect on Muscular Tone Evaluated by Functional MRI ...	Prader-Willi Syndrome	Drug: Growth hormone;Drug: Placebo	Corporacion Parc Tauli	Parc de Salut Mar	Completed	18 Years	N/A	All	30	Phase 4	Spain
9	NCT02205450 (ClinicalTrials.gov)	September 2014	30/7/2014	Experience With Growth Hormone(GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the ...	Experience With Growth Hormone(GH) in Children Under 2 Years With Prader-Willi Syndrome (PWS) in the ...	Prader-Willi Syndrome	Drug: Recombinant Somatropin	Corporacion Parc Tauli	NULL	Not yet recruiting	N/A	2 Years	Both	15	N/A	Spain
10	EUCTR2011-001313-14-NL (EUCTR)	17/10/2012	12/01/2012	Young adult Prader-Willi StudyEffects of Growth Hormoneafter final height:A clinical care study to t ...	Young adult Prader-Willi StudyEffects of Growth Hormoneafter final height:A clinical care study to t ...	Prader Willi Syndrome MedDRA version: 14.1;Level: LLT;Classification code 10041331;Term: Somatotroph ...	Trade Name: GENOTROPIN (Somatropin) is a growth hormonetreatment. It is an exact copy of the natural ...	Dutch growth research foundation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Netherlands

First Previous1 2Next Last